Harmony Biosciences Holdings insider trading

Bought

—

Sold

$3.1M

none on a 10b5-1 plan

Net

−$3.1M

Insiders

1

• Budur Kumar

  Chief Medical Officer

  −$1.5M

  Sep 18, 2026

  35,852 sh · $43.05

• Budur Kumar

  Chief Medical Officer

  −$34.4K

  Sep 17, 2026

  800 sh · $43.00

• Budur Kumar

  Chief Medical Officer

  −$77.4K

  Sep 16, 2026

  1,800 sh · $43.01

• Budur Kumar

  Chief Medical Officer

  −$190.1K

  Sep 08, 2026

  4,500 sh · $42.25

• Budur Kumar

  Chief Medical Officer

  −$42.8K

  Sep 08, 2026

  1,000 sh · $42.79

• Budur Kumar

  Chief Medical Officer

  −$989.3K

  Sep 08, 2026

  22,954 sh · $43.10

• Budur Kumar

  Chief Medical Officer

  −$230.9K

  Sep 04, 2026

  5,500 sh · $41.98

Largest sale

−$121.2M of HRMY by Valor Equity Partners Iv-B L.P. (10% Owner) on Nov 01, 2024.

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

SEC industry classification

Pharmaceutical Preparations

Headquarters

Plymouth Meeting, PA

Incorporated in

DE

Listed on

Nasdaq

SEC Central Index Key

0001802665

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

Open-market purchase (code P)

An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.

Grants and option exercises (codes A, M)

Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.

Cluster buy

Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Are HRMY insiders buying or selling?

Between Sep 04, 2026 and Sep 18, 2026, 1 Harmony Biosciences Holdings insider made no open-market purchases and 7 sales worth $3.1M, a net sale of $3.1M.

How much HRMY stock have insiders bought and sold in the last two years?

Between Jul 01, 2024 and Jun 30, 2026, 5 Harmony Biosciences Holdings insiders made no open-market purchases and 31 sales worth $290.6M. 22 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 7 sales ($3.6M). The largest sale was Valor Equity Partners Iv-B L.P. selling $121.2M on Nov 01, 2024.

What was the largest recent HRMY insider trade?

Budur Kumar (Chief Medical Officer) sold $1.5M of HRMY stock on Sep 18, 2026 at about $43.05 a share.

When did an insider last buy HRMY shares?

No open-market purchase by a Harmony Biosciences Holdings insider appears in the filings from Sep 04, 2026 to Sep 18, 2026 — every recorded open-market transaction in that period was a sale.

Where does HRMY insider trading data come from?

From the Form 4 filings Harmony Biosciences Holdings's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.